SD
LinkedIn

Shannon Dahl

Founder and Chief Executive Officer (CEO) at Carve Bio

San Francisco Bay Area · 2 connections

Carve Bio

Not on Unlinked · Imported profile. Is this you? Claim it

About

Driving Therapeutic Innovation from Discovery to Commercialization I am a visionary leader in the biotechnology industry with a longstanding reputation for transforming groundbreaking scientific research into market-ready therapies that save lives. With a strong foundation in scientific strategy and business development, I excel at guiding high-growth biotech companies through the critical phases of development. My unique blend of expertise allows me to navigate the complexities of R&D, regulators, commercialization, and reimbursement – guaranteeing that innovative therapies reach the patients who need them most. Over the course of my executive career, I have gained a holistic understanding of the biotech landscape, from early-stage research to Phase 3 clinical trials and reimbursement, as well as the growth of companies through these stages. My strategic insights have often been the key to securing significant funding, forging strategic partnerships, and building high-performing teams. Whether I’m developing a unified vision for teams to develop new therapies or I’m negotiating value-based care agreements or engaging with a range of critical stakeholders, I bring a forward-thinkin

Experience

Founder and Chief Executive Officer (CEO)Carve Bio
Oct 2021
Strategic Advisor to Chair of the Board of DirectorsInvectys
Apr 2025 to Nov 2025
Chief Scientific OfficerIolyx Therapeutics
Jan 2022
Expert-in-Residence (XIR)Digitalis Commons
Aug 2024 to Feb 2026
Strategic Advisor to CEORadar Therapeutics
Oct 2023
Strategic Advisor to CEOLaguna Bio
Aug 2024
Chief Scientific OfficerLaguna Bio
Nov 2023 to Aug 2024
Strategic Advisory BoardStrand Therapeutics
Jan 2019
Scientific Advisory BoardHepaTx Corporation
Jan 2017 to Jan 2024
Chief Business AdvisorEpicrispr Biotechnologies
Feb 2023 to Sep 2023
Interim Chief Scientific Officer4:59 NewCo, a 5AM Ventures Company
Oct 2021 to Apr 2022
Chief Scientific OfficerCell Care Therapeutics
Jan 2018 to Aug 2021
Co-Founder, Leader of Reimbursement StrategyHumacyte
Jan 2014 to Jan 2018
Co-Founder, VP Technology and Pipeline DevelopmentHumacyte
Jan 2012 to Jan 2014
Co-Founder, Senior Director of Scientific Operations | Principal ScientistHumacyte
Jan 2004 to Jan 2012
Adjunct Faculty, Department of SurgeryDuke University
Jan 2013 to Jan 2018
Research in Orthopedic SurgeryHarvard Medical School
Jan 1998 to Jan 1999

Education

Massachusetts Institute of Technology
S.B. Materials Science and Engineering (Regenerative Medicine & Biomaterials), Concentration in Economics
1995 to 1999
Duke University
Ph.D. Biomedical Engineering (Regenerative Medicine)
1999 to 2004
The George Washington University
Boardroom Ready Corporate Governance for Executive Women in Bio (adapted from Biogen's program)
2019 to 2019